Wolters Kluwer Health’s Post

Want your people to see better health outcomes? Start by changing your mindset around pharmacy services. "MOBE is focused on reducing medical utilization, not pharmacy utilization, and that's contrary to the majority of pharmacy-based programs. When we do that, we connect the dots between pharmacy use and medical outcomes." In this conversation, MOBE Senior Vice President of Health Outcomes Strategies, Leslie Helou, Pharm.D., says the key to optimizing medication use is assessing whether a medication is even needed and if it's providing a safe experience. Read the whole conversation with Leslie 👉 https://bit.ly/45nRtNl #MedicationUse #MedicationGuidance #Pharmacy #PharmacyServices #AmericanPharmacistsMonth

The surge in popularity of GLP-1 medications like Ozempic and Wegovy for weight management is exciting, but current data reveals a critical issue: over 30% of patients drop treatment within four weeks. As healthcare marketers, we must address this gap by enhancing our patient education and support strategies. Understanding the role of healthcare providers in fostering adherence is key. Let’s strategize on building comprehensive care models that keep patients engaged long-term. #HealthcareMarketing #PatientEngagement

🌟 Dive into the world of miracle drugs with Pharmacist Jonathan Gonzalez, PHARMD! 💊 Discover the game-changers like Ozempic, Wegovy, and Mounjaro that everyone's buzzing about. Jonathan breaks down the benefits, potential side effects, and more in our latest discussion! Don't miss out on this informative session. #MiracleDrugs #PharmacyTalk #Ozempic #Wegovy #Mounjaro #HealthcareHeroes #PharmacistLife #HealthAndWellness #MedicalInnovations #HealthEducation #DrugInformation #PharmacyCare #MedicalBreakthroughs #PatientCare #HealthTips #PharmacyKnowledge #WellnessWednesday #MedicationManagement #HealthAwareness #EmpowerYourHealth #HealthyLiving #PharmacyServices #StayInformed #NirvanaHealthcare #JonathanGonzalezPHARMD #NewarkNJ #EssexCountyNJ #OrangeNJ

The rising use of GLP-1 medications for diabetes and weight management brings up critical discussions about their cost and legality. In this webinar, we’ll delve into the financial implications and legal aspects of acquiring these drugs, shedding light on the broader impact on healthcare and patient access. #GroupBenefitSolutions

The rising use of GLP-1 medications for diabetes and weight management brings up critical discussions about their cost and legality. In this webinar, we’ll delve into the financial implications and legal aspects of acquiring these drugs, shedding light on the broader impact on healthcare and patient access. #GroupBenefitSolutions

Alliance for Pharmacy Compounding' Owner Summit is in full swing! Don't forget to join Ross A. Caputo, PhD presentation today at 3:30 pm to explore the intricate relationship between quality standards and economic considerations in the context of compounding pharmacy. Hope to see you there! #eagleanalytical #APC #compoundingpharmacy #patientcare #ownersummit

A new Pacific Research Institute study shows “the current system incentivizes PBMs to implement policies that benefit insurers and themselves, while making drugs less affordable and available.” Reforms to pharmacy benefit manager practices will benefit patients. #HealthCare #Law #Medicine

While cost-sharing can be expressed as a well-intended benefit design, it can negatively affect long-term drug adherence by patients. AMCP supports efforts to reduce out-of-pocket costs where appropriate, including provisions of the Inflation Reduction Act. However, there could be long-term and unintended consequences in reducing premiums, so it is crucial to develop comprehensive and patient-centric solutions to address these issues over time. AMCP, along with our partners, look forward to our continued efforts to address these complex solutions. https://bit.ly/3T6LSFH #drugpricing #healthequity #patientaccess

Rising prescription drug costs continue to be a key challenge for Michiganders. Rep. Alabas Farhat, Michael Cabonargi, Dominick Pallone, and Eric Roath, PharmD, MBA, are discussing this issue and more at the 2024 Michigan State of Reform Health Policy Conference. #Michigan #healthcare #drugaffordability

Phase 4 occurs after a drug is approved and released, focusing on tracking its long-term safety and efficacy in real-world conditions. 💡 This phase explores how the treatment works in a broader population, identifying any long-term benefits or risks that might arise over time. 📊 With 1,000+ participants, Phase 4 ensures ongoing monitoring for adverse events, and may reveal new potential uses for the drug. 🏁 It’s crucial for confirming the drug’s long-term impact and keeping patients and healthcare providers informed about its real-world performance. #clinicaltrials #phase4 #safety #medical #research #drugdevelopment